Role of H2O2 in hypertension, renin-angiotensin system activation and renal medullary disfunction caused by angiotensin II

British Journal of Pharmacology

Volumn 166, Issue 8, 2012, Pages 2386-2401

  Sousa, T ^a,b   Oliveira, S ^a,c   Afonso, J ^a   Morato, M ^a,b   Patinha, D ^a,c   Fraga, S ^b   Carvalho, F ^b   Albino Teixeira, A ^a,c  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

angiotensin II; angiotensinogen; Nox4; nuclear factor B; renal medulla

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSINOGEN; CATALASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROGOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG TARGETING; HYPERTENSION; KIDNEY CORTEX; KIDNEY DYSFUNCTION; KIDNEY MEDULLA; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; URINE LEVEL;

EID: 84864420599     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01957.x     Document Type: Article

References (63)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edn. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. Ardanaz N, Pagano PJ, (2006). Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Exp Biol Med (Maywood) 231: 237-251. (Pubitemid 43334308)
3. Asghar M, Banday AA, Fardoun RZ, Lokhandwala MF, (2006). Hydrogen peroxide causes uncoupling of dopamine D1-like receptors from G proteins via a mechanism involving protein kinase C and G-protein-coupled receptor kinase 2. Free Radic Biol Med 40: 13-20. (Pubitemid 41759399)
4. Block K, Eid A, Griendling KK, Lee DY, Wittrant Y, Gorin Y, (2008). Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. J Biol Chem 283: 24061-24076.
5. Bourcier T, Sukhova G, Libby P, (1997). The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem 272: 15817-15824. (Pubitemid 27265559)
6. Brasier AR, Jamaluddin M, Han Y, Patterson C, Runge MS, (2000). Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor. Mol Cell Biochem 212: 155-169.
7. Bruggeman LA, Adler SH, Klotman PE, (2001). Nuclear factor-kappa B binding to the HIV-1 LTR in kidney: implications for HIV-associated nephropathy. Kidney Int 59: 2174-2181. (Pubitemid 32467609)
8. Chen YF, Cowley AW Jr, Zou AP, (2003). Increased H(2)O(2) counteracts the vasodilator and natriuretic effects of superoxide dismutation by tempol in renal medulla. Am J Physiol Regul Integr Comp Physiol 285: R827-R833. (Pubitemid 37169145)
9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al,. (2003). Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252. (Pubitemid 37553153)
10. Cholewa BC, Mattson DL, (2005). Influence of elevated renin substrate on angiotensin II and arterial blood pressure in conscious mice. Exp Physiol 90: 607-612. (Pubitemid 40980161)
11. Colston JT, de la Rosa SD, Strader JR, Anderson MA, Freeman GL, (2005). H2O2 activates Nox4 through PLA2-dependent arachidonic acid production in adult cardiac fibroblasts. FEBS Lett 579: 2533-2540. (Pubitemid 40569533)
12. Cowley AW Jr, (2008). Renal medullary oxidative stress, pressure-natriuresis, and hypertension. Hypertension 52: 777-786.
13. Cowley AW Jr, Mattson DL, Lu S, Roman RJ, (1995). The renal medulla and hypertension. Hypertension 25: 663-673.
14. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, et al,. (2006). Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 103: 17985-17990. (Pubitemid 44852272)
15. Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HH, Harrison DG, Griendling KK, (2008). Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med 45: 1340-1351.
16. Dinis-Oliveira RJ, Sousa C, Remiao F, Duarte JA, Navarro AS, Bastos ML, et al,. (2007). Full survival of paraquat-exposed rats after treatment with sodium salicylate. Free Radic Biol Med 42: 1017-1028. (Pubitemid 46356893)
17. Droge W, (2002). Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95. (Pubitemid 34654215)
18. El Jamali A, Valente AJ, Lechleiter JD, Gamez MJ, Pearson DW, Nauseef WM, et al,. (2008). Novel redox-dependent regulation of NOX5 by the tyrosine kinase c-Abl. Free Radic Biol Med 44: 868-881.
19. El Jamali A, Valente AJ, Clark RA, (2010). Regulation of phagocyte NADPH oxidase by hydrogen peroxide through a Ca(2+)/c-Abl signaling pathway. Free Radic Biol Med 48: 798-810.
20. Fardoun RZ, Asghar M, Lokhandwala M, (2007). Role of nuclear factor kappa B (NF-kappaB) in oxidative stress-induced defective dopamine D1 receptor signaling in the renal proximal tubules of Sprague-Dawley rats. Free Radic Biol Med 42: 756-764. (Pubitemid 46274166)
21. Ferrario CM, (2010). Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control. Life Sci 86: 289-299.
22. Gao YJ, Lee RM, (2001). Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A(2) production. Br J Pharmacol 134: 1639-1646. (Pubitemid 34038096)
23. Gao YJ, Hirota S, Zhang DW, Janssen LJ, Lee RM, (2003). Mechanisms of hydrogen-peroxide-induced biphasic response in rat mesenteric artery. Br J Pharmacol 138: 1085-1092. (Pubitemid 36459831)
24. Gao YJ, Zhang Y, Hirota S, Janssen LJ, Lee RM, (2004). Vascular relaxation response to hydrogen peroxide is impaired in hypertension. Br J Pharmacol 142: 143-149. (Pubitemid 38698203)
25. Garrido AM, Griendling KK, (2009). NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 302: 148-158.
26. Geiszt M, Kopp JB, Varnai P, Leto TL, (2000). Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A 97: 8010-8014. (Pubitemid 30460764)
27. Giles TD, (2006). Assessment of global risk: a foundation for a new, better definition of hypertension. J Clin Hypertens (Greenwich) 8: 5-14.
28. Gongora MC, Qin Z, Laude K, Kim HW, McCann L, Folz JR, et al,. (2006). Role of extracellular superoxide dismutase in hypertension. Hypertension 48: 473-481. (Pubitemid 44253743)
29. Guan H, Hou S, Ricciardi RP, (2005). DNA binding of repressor nuclear factor-kappaB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit. J Biol Chem 280: 9957-9962. (Pubitemid 40395844)
30. Heumuller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schroder K, et al,. (2008). Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51: 211-217. (Pubitemid 351159930)
31. Jamaluddin M, Meng T, Sun J, Boldogh I, Han Y, Brasier AR, (2000). Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-kappaB activation. Mol Endocrinol 14: 99-113. (Pubitemid 32260330)
32. Jones DP, (2008). Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 295: C849-C868.
33. Kobori H, Harrison-Bernard LM, Navar LG, (2002). Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int 61: 579-585. (Pubitemid 34102599)
34. Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG, (2003). Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension. Hypertension 41: 42-49. (Pubitemid 36056790)
35. Kobori H, Prieto-Carrasquero MC, Ozawa Y, Navar LG, (2004). AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 43: 1126-1132. (Pubitemid 38579925)
36. Kobori H, Nangaku M, Navar LG, Nishiyama A, (2007). The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251-287. (Pubitemid 47481436)
37. Kobori H, Katsurada A, Miyata K, Ohashi N, Satou R, Saito T, et al,. (2008). Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA. Am J Physiol Renal Physiol 294: F1257-F1263.
38. Kobori H, Alper AB Jr, Shenava R, Katsurada A, Saito T, Ohashi N, et al,. (2009). Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension 53: 344-350.
39. Lacy F, O'Connor DT, Schmid-Schonbein GW, (1998). Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 16: 291-303. (Pubitemid 28101757)
40. Lacy F, Kailasam MT, O'Connor DT, Schmid-Schonbein GW, Parmer RJ, (2000). Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 36: 878-884.
41. Lin HH, Chen CH, Hsieh WK, Chiu TH, Lai CC, (2003). Hydrogen peroxide increases the activity of rat sympathetic preganglionic neurons in vivo and in vitro. Neuroscience 121: 641-647. (Pubitemid 38367503)
42. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
43. Makino A, Skelton MM, Zou AP, Cowley AW Jr, (2003). Increased renal medullary H2O2 leads to hypertension. Hypertension 42: 25-30. (Pubitemid 36842232)
44. Malle E, Buch T, Grone HJ, (2003). Myeloperoxidase in kidney disease. Kidney Int 64: 1956-1967. (Pubitemid 37449530)
45. Milik E, Szczepanska-Sadowska E, Cudnoch-Jedrzejewska A, Dobruch J, Morton M, Koperski L, (2006). Upregulation of angiotensin AT1a receptors mRNA in the heart and renal medulla after myocardial infarction in rats. J Physiol Pharmacol 57: 375-388. (Pubitemid 44543873)
46. Morigi M, Macconi D, Zoja C, Donadelli R, Buelli S, Zanchi C, et al,. (2002). Protein overload-induced NF-kappaB activation in proximal tubular cells requires H(2)O(2) through a PKC-dependent pathway. J Am Soc Nephrol 13: 1179-1189. (Pubitemid 34441398)
47. Nagata S, Kato J, Sasaki K, Minamino N, Eto T, Kitamura K, (2006). Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system. Biochem Biophys Res Commun 350: 1026-1031. (Pubitemid 44596223)
48. Nistala R, Whaley-Connell A, Sowers JR, (2008). Redox control of renal function and hypertension. Antioxid Redox Signal 10: 2047-2089.
49. Okada S, Kozuka C, Masuzaki H, Yasue S, Ishii-Yonemoto T, Tanaka T, et al,. (2010). Adipose tissue-specific dysregulation of angiotensinogen by oxidative stress in obesity. Metabolism 59: 1241-1251.
50. Orient A, Donko A, Szabo A, Leto TL, Geiszt M, (2007). Novel sources of reactive oxygen species in the human body. Nephrol Dial Transplant 22: 1281-1288. (Pubitemid 47072211)
51. Paravicini TM, Touyz RM, (2006). Redox signaling in hypertension. Cardiovasc Res 71: 247-258.
52. Pereira SG, Oakley F, (2008). Nuclear factor-kappaB1: regulation and function. Int J Biochem Cell Biol 40: 1425-1430.
53. Rodriguez-Martinez MA, Garcia-Cohen EC, Baena AB, Gonzalez R, Salaices M, Marin J, (1998). Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved. Br J Pharmacol 125: 1329-1335. (Pubitemid 28542544)
54. Schluter T, Grimm R, Steinbach A, Lorenz G, Rettig R, Grisk O, (2006). Neonatal sympathectomy reduces NADPH oxidase activity and vascular resistance in spontaneously hypertensive rat kidneys. Am J Physiol Regul Integr Comp Physiol 291: R391-R399. (Pubitemid 44035646)
55. Sedeek M, Callera G, Montezano A, Gutsol A, Heitz F, Szyndralewiez C, et al,. (2010). Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am J Physiol Renal Physiol 299: F1348-F1358.
56. Sousa T, Pinho D, Morato M, Marques-Lopes J, Fernandes E, Afonso J, et al,. (2008). Role of superoxide and hydrogen peroxide in hypertension induced by an antagonist of adenosine receptors. Eur J Pharmacol 588: 267-276.
57. Thakali K, Davenport L, Fink GD, Watts SW, (2006). Pleiotropic effects of hydrogen peroxide in arteries and veins from normotensive and hypertensive rats. Hypertension 47: 482-487. (Pubitemid 43740294)
58. Ungvari Z, Orosz Z, Labinskyy N, Rivera A, Xiangmin Z, Smith K, et al,. (2007). Increased mitochondrial H2O2 production promotes endothelial NF-kappaB activation in aged rat arteries. Am J Physiol Heart Circ Physiol 293: H37-H47. (Pubitemid 47108162)
59. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J, (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84. (Pubitemid 44566469)
60. Vejrazka M, Micek R, Stipek S, (2005). Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells. Biochim Biophys Acta 1722: 143-147. (Pubitemid 40299004)
61. Wesseling S, Ishola DA Jr, Joles JA, Bluyssen HA, Koomans HA, Braam B, (2005). Resistance to oxidative stress by chronic infusion of angiotensin II in mouse kidney is not mediated by the AT2 receptor. Am J Physiol Renal Physiol 288: F1191-F1200. (Pubitemid 40677089)
62. Yang H, Shi M, VanRemmen H, Chen X, Vijg J, Richardson A, et al,. (2003). Reduction of pressor response to vasoconstrictor agents by overexpression of catalase in mice. Am J Hypertens 16: 1-5. (Pubitemid 36078583)
63. Yuan B, Liang M, Yang Z, Rute E, Taylor N, Olivier M, et al,. (2003). Gene expression reveals vulnerability to oxidative stress and interstitial fibrosis of renal outer medulla to nonhypertensive elevations of ANG II. Am J Physiol Regul Integr Comp Physiol 284: R1219-R1230. (Pubitemid 36457564)